Clinical Trial Update: STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [Phase 3]

View source ↗

Summary

This document reports a Phase 3 trial comparing imatinib (STI571) with interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. The study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelogenous Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Gleevec (Imatinib)
• Interferon Alfa (interferon alfa)

Snippet

Sponsor: Novartis | Conditions: Leukemia | Phase 3 | Status: COMPLETED